Browse through a myriad of stories, facts and figures, testimonials and cases that show why Flanders is a life sciences & health hub that truly pushes boundaries.
Flanders is the European champion in clinical trials
With 526 clinical trials per capita in 2019, Belgium and its northern region Flanders are in the European top 3 for clinical trials.
30,000 m² of temperature-controlled pharma logistics space
Brussels Airport’s biggest asset? The largest area of temperature-controlled pharmaceutical warehouses for medicines and vaccines of all European airports. The area doubled in size in five years’ time.
‘Mission Lucidity’: fighting dementia thanks to pioneering work in Flanders
The ambitious project aims to build a data and knowledge platform that accelerates the fight against Alzheimer’s and make it more focused. How? Through collaboration with tech companies from Flanders.
3 times in a row: European biotech leader
In 2020, for the 3rd year in a row, Belgium can call itself “the European biotech leader” thanks to these figures
24% of the total European market value;
56% rise in the value of local biotech companies;
60+ new local start-ups in the last 5 years.
30 times faster: coronavirus detection
Developed in Flanders, UgenTec software detects the coronavirus 30 times faster than usual, acting as a true lifesaver for labs around the globe.
Did you know… Flanders is a pioneer in the 3D printing of human tissues?
Xpect-INX, a spin-off of Ghent University (Flanders), is developing unique ‘bio-inks’. This will enable the 3D printing of biological tissues and, in time, even entire human organs.
Clinical blood analysis leaders join forces in Flanders
CMA-Medina (Flanders) and Biogroup (France), two private groups for clinical blood analyses, aim to reinforce their local position and expand in Europe. The transaction makes the combined Belgian-French lab group one of the main European players
Made in Flanders: pioneering glucose monitoring sensor
Indigo Diabetes, a spin-off of Flanders’ strategic research center for nano- and digital tech (imec), is working on the world’s first hypodermic sensor for diabetics. This CGM system offers a pain-free alternative for monitoring blood glucose levels.
“Working together with Flanders’ hospitals allowed us to perfect our medical AI platform.”
The figures tell the tale of Flanders’ biopharma track record
EUR 3.8 billion invested in R&D;
38,500 direct jobs;
EUR 49.8 billion in exports.
These are just a few figures from a 2020 study by pharma.be on Flanders’ leading biopharma sector!
Flanders in the battle against bacterial resistance
Aelin Therapeutics, a Flanders-based biotech pioneer and spin-off of strategic research center VIB, is working with universities KU Leuven, VUB and UGent to develop new methods to defeat drug-resistant bacteria.
